CMV and Immunosenescence: from basics to clinics
Mostra el registre complet Registre parcial de l'ítem
- dc.contributor.author Solana, Rafaelca
- dc.contributor.author Tarazona, Raquelca
- dc.contributor.author Aiello, Allison E.ca
- dc.contributor.author Akbar, Arne N.ca
- dc.contributor.author Appay, Victorca
- dc.contributor.author Beswick, Markca
- dc.contributor.author Bosch, Jos A.ca
- dc.contributor.author Campos, Carmenca
- dc.contributor.author Cantisán, Saraca
- dc.contributor.author Cicin Sain, Lucaca
- dc.contributor.author Derhovanessian, Evelynaca
- dc.contributor.author Ferrando Martínez, Saraca
- dc.contributor.author Frasca, Danielaca
- dc.contributor.author Fulöp, Tamasca
- dc.contributor.author Govind, Sheilaca
- dc.contributor.author Grubeck Loebenstein, Beatrixca
- dc.contributor.author Hill, Annca
- dc.contributor.author Hurme, Mikkoca
- dc.contributor.author Kern, Florianca
- dc.contributor.author Larbi, Anisca
- dc.contributor.author López-Botet, M. (Miguel)ca
- dc.contributor.author Maier, Andrea B.ca
- dc.contributor.author McElhaney, Janet E.ca
- dc.contributor.author Moss, Paulca
- dc.contributor.author Naumova, Elissavetaca
- dc.contributor.author Nikolich Zugich, Jankoca
- dc.contributor.author Pera, Alejandraca
- dc.contributor.author Rector, Jerrarld L.ca
- dc.contributor.author Riddell, Natalieca
- dc.contributor.author Sanchez Correa, Beatrizca
- dc.contributor.author Sansoni, Paoloca
- dc.contributor.author Sauce, Delphineca
- dc.contributor.author Lier, Rene vanca
- dc.contributor.author Wang, George C.ca
- dc.contributor.author Wills, Mark R.ca
- dc.contributor.author Zielinski, Maciejca
- dc.contributor.author Pawelec, Grahamca
- dc.date.accessioned 2015-03-16T08:16:24Z
- dc.date.available 2015-03-16T08:16:24Z
- dc.date.issued 2012ca
- dc.description.abstract Alone among herpesviruses, persistent Cytomegalovirus (CMV) markedly alters the numbers and proportions of peripheral immune cells in infected-vs-uninfected people. Because the rate of CMV infection increases with age in most countries, it has been suggested that it drives or at least exacerbates “immunosenescence”. This contention remains controversial and was the primary subject of the Third International Workshop on CMV & Immunosenescence which was held in Cordoba, Spain, 15-16th March, 2012. Discussions focused on several main themes including the effects of CMV on adaptive immunity and immunosenescence, characterization of CMV-specific T cells, impact of CMV infection and ageing on innate immunity, and finally, most important, the clinical implications of immunosenescence and CMV infection. Here we summarize the major findings of this workshop.en
- dc.description.sponsorship The Workshop was partially supported by the University of Cordoba and the Spanish Ministry of Science (SAF2011-16169-E)en
- dc.format.mimetype application/pdfca
- dc.identifier.citation Solana R, Tarazona R, Aiello AE, Akbar AN, Appay V, Beswick M et al. CMV and Immunosenescence: from basics to clinics. Immunity & Ageing. 2012; 9: 23. DOI 10.1186/1742-4933-9-23ca
- dc.identifier.doi http://dx.doi.org/10.1186/1742-4933-9-23
- dc.identifier.issn 1742-4933ca
- dc.identifier.uri http://hdl.handle.net/10230/23187
- dc.language.iso engca
- dc.publisher BioMed Centralca
- dc.relation.ispartof Immunity & Ageing. 2012; 9: 23
- dc.relation.projectID info:eu-repo/grantAgreement/ES/3PN/SAF2011-16169
- dc.rights © 2012 Solana et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.ca
- dc.rights.accessRights info:eu-repo/semantics/openAccessca
- dc.rights.uri http://creativecommons.org/licenses/by/2.0
- dc.subject.other Immunitat cel·lularca
- dc.title CMV and Immunosenescence: from basics to clinicsca
- dc.type info:eu-repo/semantics/articleca
- dc.type.version info:eu-repo/semantics/publishedVersionca